Pamela I. Causa Andrieu, MD
MRI, CT scan, and ultrasound; gynecologic and genitourinary cancers
Contact and Location
Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
MD, Universidad Nacional de La Plata — Facultad de Ciencias Medicas, Argentina
Diagnostic Imaging Residency, Hospital Italiano de Buenos Aires, Argentina
Body Imaging Fellowship, Hospital Italiano de Buenos Aires, Argentina; Comprehensive MRI Oncologic Imaging Fellowship, Memorial Sloan Kettering Cancer Center
I am a board-certified radiologist specializing in cancer imaging of the chest, abdomen, and pelvis using MRI, CT scan, and ultrasound. I work on the Gynecology and Genitourinary Disease Management teams with surgeons, oncologists, pathologists, and radiation therapy physicians. It is very rewarding to be able to collaborate with the team and to provide my input toward the overall management of our patients.
My main research interests are imaging innovation, radiomics, and machine learning. I seek to enhance and integrate the existing multimodality imaging techniques and support the development of new imaging methods to aid in the diagnosis and ongoing care of patients with gynecological and genitourinary cancers. We are applying radiomics — a computer-based medical image analysis — to predict tumor features such as pathology, genetics, and treatment response.
I joined the Memorial Sloan Kettering team in 2019. I am fortunate and grateful to be part of such an esteemed institution, where there are collective efforts to provide the best care for patients with cancer. I am committed to contributing to patient care by delivering accurate and actionable reports.
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Pamela I. Causa Andrieu discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2020 through disclosure submission in spring 2021). This data reflects interests that may or may not still exist. This data is updated annually.